4//SEC Filing
LAROSA JOSEPH J 4
Accession 0001883850-24-000036
CIK 0000872589other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:39 PM ET
Size
8.8 KB
Accession
0001883850-24-000036
Insider Transaction Report
Form 4
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-06-24−14,450→ 14,450 totalExercise: $555.67Exp: 2025-12-16→ Common Stock (14,450 underlying) - Tax Payment
Common Stock
2024-06-24$1060.13/sh−11,084$11,750,481→ 39,803 total - Exercise/Conversion
Common Stock
2024-06-24$555.67/sh+14,450$8,029,431→ 50,887 total
Holdings
- 371(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001238303
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:39 PM ET
- Size
- 8.8 KB